Issue 7, 2015

Engineering DNA scaffolds for delivery of anticancer therapeutics

Abstract

Engineering DNA nanostructures with programmability in size, shape and surface chemistry holds tremendous promise in biomedical applications. As an emerging platform for drug delivery, DNA nanostructures have been extensively studied for delivering anticancer therapeutics, including small-molecule drug, nucleic acids and proteins. In this mini-review, current advances in utilizing DNA scaffolds as drug carriers for cancer treatment were summarized and future challenges were also discussed.

Graphical abstract: Engineering DNA scaffolds for delivery of anticancer therapeutics

Article information

Article type
Minireview
Submitted
29 déc. 2014
Accepted
13 févr. 2015
First published
25 févr. 2015

Biomater. Sci., 2015,3, 1018-1024

Engineering DNA scaffolds for delivery of anticancer therapeutics

W. Sun and Z. Gu, Biomater. Sci., 2015, 3, 1018 DOI: 10.1039/C4BM00459K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements